Meniere's Disease Management

Diagnosis and Monitoring

• A stepwise approach is recommended for Meniere's disease management, starting with conservative measures and progressing to more invasive interventions, guided by symptom severity and response to therapy, as suggested by the American Academy of Otolaryngology-Head and Neck Surgery 1
• An audiogram is essential for diagnosis and monitoring progression of Meniere's disease, and should be obtained when assessing a patient for Meniere's disease, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2, 1
• Documenting patient symptom history, including episodes of vertigo, hearing loss patterns, tinnitus, and aural fullness, is crucial for diagnosis and treatment planning 1
• Video- or electronystagmogram and electrocochleography may be used to evaluate vestibular function and measure electrical responses of the cochlea and auditory nerve, respectively, although they may cause vertigo and nausea during testing 1
• Baseline severity of vertigo, tinnitus, and hearing loss should be documented, and regular follow-up scheduled to assess symptom improvement or worsening, with serial audiograms performed to monitor hearing function, and the impact on quality of life assessed 1

Treatment

• Antivertigo medications, such as vestibular suppressants (including benzodiazepines and antiemetics), are recommended for symptomatic relief of Meniere's disease, to be used for a limited course only, with caution for risk of dependence, sedation, and impaired vestibular compensation, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2, 1
• Diuretics, such as thiazides, potassium-sparing diuretics, and loop diuretics, may be offered to reduce endolymph volume, although high-quality evidence supporting efficacy is limited 2, 1
• Betahistine may be considered at dosages of 16-48 mg daily, with caution in patients with asthma or peptic ulcer disease, although high-quality evidence for efficacy is limited 2, 1
• Intratympanic steroid injections can improve vertigo symptoms, with 85-90% improvement compared to 57-80% with conventional therapy, and may be considered in combination with betahistine for enhanced efficacy 1
• Intratympanic gentamicin can achieve complete vertigo control in approximately 73.6% of patients, but carries a risk of hearing loss (25.1% overall) and is contraindicated in patients with contralateral disease or known hypersensitivity to aminoglycosides 1
• Vestibular rehabilitation (physical therapy) can be beneficial for chronic imbalance between attacks, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
• Hearing aids can be beneficial for patients with hearing loss due to Meniere's disease, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2, 1

Lifestyle Modifications

• The American Academy of Otolaryngology-Head and Neck Surgery recommends considering lifestyle modifications, including a low-sodium diet (1500-2300 mg daily), limiting alcohol and caffeine intake, managing stress, and sleeping in darkness, to reduce symptoms 1, 2
• Keeping a food diary to identify personal triggers may be helpful, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1, 2
• Cooling measures, such as limiting ice or water immersion and elevating extremities, may provide symptom relief 3

Surgical Interventions

• Vestibular nerve section is a hearing-sparing procedure that may be considered for severe cases, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
• Labyrinthectomy may be considered for severe cases with profound hearing loss, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
• Endolymphatic sac decompression is a hearing-preserving procedure that may be used to treat Meniere's disease, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1

Follow-up and Quality of Life Assessment

• Regular follow-up with serial audiograms is essential to track disease progression and treatment response, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
• Regular evaluation of how symptoms impact daily functioning and psychological wellbeing is recommended for patients with Meniere's disease, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1
• Patient education should include verbal and written information about the disease, treatment options, and the quality of life impact, including psychological aspects such as anxiety, depression, and social isolation, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 4, 1
• Patients should be counseled about the natural history, measures for symptom control, treatment options, and outcomes, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 2
• About 10-25% of patients develop bilateral Meniere's disease over time, which impacts treatment decisions, especially regarding ablative therapies, as noted by the American Academy of Otolaryngology-Head and Neck Surgery 1
• There is no cure for Meniere's disease, only symptom management, and treatment expectations should be discussed with patients, informing them of potential long-term effects, as recommended by the American Academy of Otolaryngology-Head and Neck Surgery 1